Search - tctmd.com

Displaying 261 - 280 of 345

Sort: Relevancy | Date

News Daily News

The Higher the LDL, the Bigger the Mortality Benefit of Intensive Therapy: Meta-analysis

Michael O'Riordan

April 20, 2018

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for March 2018

Shelley Wood

April 02, 2018

News Conference News ACC 2018

SECURE-PCI Comes Up Short for Statin Preloading in ACS Patients

Michael O'Riordan

March 11, 2018

News Conference News ACC 2018

ACC 2018, Day One: Live From Orlando! The ODYSSEY Begins

Shelley Wood

March 10, 2018

News Conference News ACC 2018

Flu Vaccine Reduces Mortality, Hospitalization in HF Patients: Meta-analysis

Michael O'Riordan

March 01, 2018

News Conference News ISC 2018

COMPASS Analysis Explores Impact of Low-Dose Rivaroxaban Plus Aspirin on Stroke

Todd Neale

January 25, 2018

News Daily News

Sixfold Higher Risk of Acute MI in the Week After Flu Diagnosis

Michael O'Riordan

January 24, 2018

News Daily News

Synopsis of New Hypertension Guidelines Renews Concerns and Controversy

L.A. McKeown

January 22, 2018

News Daily News

High Rate of Clinical Events at 6 Months for Ischemic CVD Patients

Michael O'Riordan

January 19, 2018

News Daily News

Role of Lp(a) Still to Be Determined, but NHLBI Sees a Path Forward

Michael O'Riordan

January 09, 2018

News Daily News

NOACs May Carry Lower Risk of Intraocular Hemorrhage Than Warfarin

L.A. McKeown

January 02, 2018

News Daily News

Coronary CTA in the ED for Chest Pain Ups Statins, Aspirin on Discharge in Those at Highest Risk

Yael L. Maxwell

December 12, 2017

News Daily News

Subclinical Atherosclerosis Evident in Half of Adults Without CVD Risk Factors

Michael O'Riordan

December 12, 2017

News Daily News

USPSTF Upholds Stance Against Hormone Therapy to Prevent Chronic Diseases in Menopausal Women

Caitlin E. Cox

December 12, 2017

News Daily News

Genetic Study Hints at Role of Lipids in AAA Risk

Michael O'Riordan

November 30, 2017

News Conference News AHA 2017

‘De-escalating’ P2Y12 Inhibition Possible in Acute MI Patients: PRAGUE-18

Michael O'Riordan

November 15, 2017

News Daily News

NOAC Bleeding Risk Rises With Several Drug Combinations

Michael O'Riordan

October 06, 2017

News Daily News

Hormone Therapy Doesn’t Impact Long-term All-Cause, CV, or Cancer Mortality: WHI Analysis

Caitlin E. Cox

September 14, 2017

News Conference News ESC 2017

Leaflet Thrombosis After TAVR Tied to Cardiogenic Shock and Death

Yael L. Maxwell

September 01, 2017

News Conference News ESC 2017

Anacetrapib Finds (Modest) Success Where All Other CETP Inhibitors Failed

Michael O'Riordan

August 29, 2017

Advertisement

The Higher the LDL, the Bigger the Mortality Benefit of Intensive Therapy: Meta-analysis

TCTMD’s Top 10 Most Popular Stories for March 2018

SECURE-PCI Comes Up Short for Statin Preloading in ACS Patients

ACC 2018, Day One: Live From Orlando! The ODYSSEY Begins

Flu Vaccine Reduces Mortality, Hospitalization in HF Patients: Meta-analysis

COMPASS Analysis Explores Impact of Low-Dose Rivaroxaban Plus Aspirin on Stroke

Sixfold Higher Risk of Acute MI in the Week After Flu Diagnosis

Synopsis of New Hypertension Guidelines Renews Concerns and Controversy

High Rate of Clinical Events at 6 Months for Ischemic CVD Patients

Role of Lp(a) Still to Be Determined, but NHLBI Sees a Path Forward

NOACs May Carry Lower Risk of Intraocular Hemorrhage Than Warfarin

Coronary CTA in the ED for Chest Pain Ups Statins, Aspirin on Discharge in Those at Highest Risk

Subclinical Atherosclerosis Evident in Half of Adults Without CVD Risk Factors

USPSTF Upholds Stance Against Hormone Therapy to Prevent Chronic Diseases in Menopausal Women

Genetic Study Hints at Role of Lipids in AAA Risk

‘De-escalating’ P2Y12 Inhibition Possible in Acute MI Patients: PRAGUE-18

NOAC Bleeding Risk Rises With Several Drug Combinations

Hormone Therapy Doesn’t Impact Long-term All-Cause, CV, or Cancer Mortality: WHI Analysis

Leaflet Thrombosis After TAVR Tied to Cardiogenic Shock and Death

Anacetrapib Finds (Modest) Success Where All Other CETP Inhibitors Failed

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content